JP2021154220A - Water treatment agent composition and water treatment method - Google Patents

Water treatment agent composition and water treatment method Download PDF

Info

Publication number
JP2021154220A
JP2021154220A JP2020057325A JP2020057325A JP2021154220A JP 2021154220 A JP2021154220 A JP 2021154220A JP 2020057325 A JP2020057325 A JP 2020057325A JP 2020057325 A JP2020057325 A JP 2020057325A JP 2021154220 A JP2021154220 A JP 2021154220A
Authority
JP
Japan
Prior art keywords
formula
water treatment
hydrogen atom
treatment agent
agent composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020057325A
Other languages
Japanese (ja)
Other versions
JP7465699B2 (en
Inventor
雅人 都司
Masahito Toshi
雅人 都司
昌平 山本
Shohei Yamamoto
昌平 山本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organo Corp
Original Assignee
Organo Corp
Japan Organo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organo Corp, Japan Organo Co Ltd filed Critical Organo Corp
Priority to JP2020057325A priority Critical patent/JP7465699B2/en
Publication of JP2021154220A publication Critical patent/JP2021154220A/en
Application granted granted Critical
Publication of JP7465699B2 publication Critical patent/JP7465699B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Treatment Of Water By Oxidation Or Reduction (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

To provide a water treatment agent composition which is formulated as one agent with a scale inhibitor while preventing slime inhibiting performance of an oxidant-based sterilization composition from being significantly lowered, and to provide a water treatment method using the water treatment agent composition.SOLUTION: A water treatment agent composition comprises: an iodine-based oxidant; at least one of an iodide and an alkaline agent; and a scale inhibitor. There is also provided a water treatment method using the water treatment agent composition.SELECTED DRAWING: None

Description

本発明は、水系の生物付着等を抑制するための水処理剤組成物、および、その水処理剤組成物を用いた水処理方法に関する。 The present invention relates to a water treatment agent composition for suppressing biofouling of an aqueous system, and a water treatment method using the water treatment agent composition.

冷却水系、冷温水系、純水製造工程水系、排水回収工程水系、紙パルプ工程水系、集塵水系等の様々な水系において、菌類や藻類等に起因する様々な障害が発生することがある。例えば、冷却水系等においては、熱交換器内等でのスライム発生による熱交換率の低下や、配管等のスライム堆積下部で発生する微生物腐食等の障害が知られている。 Various disorders caused by fungi, algae, etc. may occur in various water systems such as cooling water system, cold / hot water system, pure water production process water system, wastewater recovery process water system, paper pulp process water system, and dust collecting water system. For example, in a cooling water system or the like, it is known that the heat exchange rate decreases due to the generation of slime in a heat exchanger or the like, and that microbial corrosion occurs in the lower part of slime deposits such as pipes.

このような菌類や藻類等に起因する障害を抑制する方法としては、殺菌剤組成物を水系に添加する方法が一般に用いられている。殺菌剤としては、イソチアゾロン化合物等の有機系の殺菌剤や、次亜塩素酸等の酸化剤系の殺菌剤等が用いられている。このうち、殺菌効果、コスト等の点から、酸化剤系の殺菌剤組成物が有利となる場合が多く、そのため、これら酸化剤系の殺菌剤組成物は様々な水系において広く使用されている。酸化剤系の殺菌剤組成物の例としては、特許文献1,2のようなクロロスルファミン酸が知られている。 As a method for suppressing damage caused by such fungi, algae and the like, a method of adding a fungicide composition to an aqueous system is generally used. As the disinfectant, an organic disinfectant such as an isothiazolone compound, an oxidizing disinfectant such as hypochlorous acid, and the like are used. Of these, oxidant-based bactericidal compositions are often advantageous in terms of bactericidal effect, cost, and the like, and therefore, these oxidant-based bactericidal compositions are widely used in various water systems. Chlorosulfamic acid as in Patent Documents 1 and 2 is known as an example of an oxidant-based bactericidal composition.

これらの酸化剤系の殺菌剤組成物とスケール抑制剤とを併せて使用する場合、複数の薬液タンクと送液ポンプが必要となり、管理に手間が掛かる問題があった。また、酸化剤系の殺菌剤組成物とスケール抑制剤とを適切な比率で水系に供給する必要があり、例えば酸化剤系の殺菌剤組成物がスケール抑制剤と比べて過剰に添加された場合、その酸化力によりスケール抑制剤が分解し、スケールが発生してしまうおそれがあった。 When these oxidant-based disinfectant compositions and scale inhibitors are used in combination, a plurality of chemical liquid tanks and liquid feed pumps are required, which causes a problem that management is troublesome. Further, it is necessary to supply the oxidant-based fungicide composition and the scale inhibitor in an appropriate ratio to the aqueous system. For example, when the oxidant-based fungicide composition is excessively added as compared with the scale inhibitor. , There was a risk that the scale inhibitor would decompose due to its oxidizing power and scale would be generated.

このため、酸化力の高い酸化剤系の殺菌剤組成物と、スケール抑制剤とができるだけ一定の割合で水系に供給されることが望ましく、酸化剤系の殺菌剤組成物とスケール抑制剤とを一剤化することが最も望ましい。 Therefore, it is desirable that the oxidant-based bactericidal composition having high oxidizing power and the scale inhibitor are supplied to the aqueous system at a constant ratio as much as possible, and the oxidant-based bactericidal composition and the scale inhibitor are used. It is most desirable to make it a single agent.

例えば、特許文献3では、次亜塩素酸ナトリウム等の塩素系酸化剤と、スルファミン酸化合物と、スケール抑制剤であるアニオン性ポリマとを含有してなり、pH12以上である一剤化のスライム防止用組成物を提示している。しかしながら、特許文献3のスライム防止用組成物では、塩素系酸化剤とスルファミン酸とを反応させ、クロロスルファミン酸として安定化させているため、組成物の安定性は増すものの、スライム抑制剤の酸化力、すなわちスライム抑制性能が著しく低下してしまう問題があった。 For example, in Patent Document 3, a chlorine-based oxidizing agent such as sodium hypochlorite, a sulfamic acid compound, and an anionic polymer which is a scale inhibitor are contained, and a single agent slime prevention having a pH of 12 or more is prevented. The composition for use is presented. However, in the slime prevention composition of Patent Document 3, since the chlorine-based oxidizing agent and sulfamic acid are reacted and stabilized as chlorosulfamic acid, the stability of the composition is increased, but the oxidation of the slime inhibitor There is a problem that the force, that is, the slime suppression performance is remarkably lowered.

特開2006−206608号公報Japanese Unexamined Patent Publication No. 2006-206608 特許第3832399号公報Japanese Patent No. 3832399 国際公開第2003/096810号パンフレットInternational Publication No. 2003/09680 Pamphlet

本発明の目的は、酸化剤系殺菌組成物のスライム抑制性能の著しい低下を抑制しつつ、スケール抑制剤を配合した一剤化された水処理剤組成物、およびその水処理剤組成物を用いた水処理方法を提供することにある。 An object of the present invention is to use a one-part water treatment agent composition containing a scale inhibitor while suppressing a significant decrease in slime suppression performance of an oxidizing agent-based bactericidal composition, and a water treatment agent composition thereof. It is to provide a water treatment method that has been used.

本発明は、ヨウ素系酸化剤と、ヨウ化物およびアルカリ剤のうちの少なくとも1つと、スケール抑制剤と、を含む、水処理剤組成物である。 The present invention is a water treatment agent composition containing an iodine-based oxidizing agent, at least one of an iodide and an alkaline agent, and a scale inhibitor.

前記水処理剤組成物において、前記スケール抑制剤は、式(1)の単量体単位を含む重合体、式(2)の単量体単位を含む重合体、式(1)の単量体単位と式(3)の単量体単位とを含む共重合体、式(1)の単量体単位と式(3)の単量体単位と式(4)の単量体単位とを含む共重合体、式(2)の単量体単位と式(5)の単量体単位と式(6)の単量体単位とを含む共重合体、式(7)のホスフィノカルボン酸共重合体、式(8)のビス(ポリ−2−カルボキシエチル)ホスフィン酸、式(9)の2−ホスホノブタン−1,2,4−トリカルボン酸およびその塩、式(10)の1−ヒドロキシエチリデン−1,1−ジホスホン酸およびその塩のうちの少なくとも1つであることが好ましい。

Figure 2021154220
(1)
(式(1)中、Rは水素原子またはメチル基を表し、Xは水素原子、1価もしくは2価の金属原子、アンモニウム基または有機アンモニウム基を表す。)
Figure 2021154220
(2)
(式(2)中、RとRはそれぞれ独立に水素原子またはメチル基を表し、XとXはそれぞれ独立に水素原子、1価もしくは2価の金属原子、アンモニウム基または有機アンモニウム基を表す。)
Figure 2021154220
(3)
(式(3)中、Rは水素原子またはメチル基を表し、Xは炭素数1〜10のアルキルスルホン酸基もしくはその塩、または、炭素数6〜10のアリールスルホン酸基もしくはその塩を表し、塩の場合は1価もしくは2価の金属塩、アンモニウム塩または有機アンモニウム塩である。)
Figure 2021154220
(4)
(式(4)中、Rは水素原子またはメチル基を表し、XとXはそれぞれ独立に水素原子または炭素数1〜10のアルキル基を表すが、少なくとも一方が炭素数1〜10のアルキル基である。)
Figure 2021154220
(5)
(式(5)中、Rは水素原子またはメチル基を表し、Xは炭素数1〜10のアルキル基である。)
Figure 2021154220
(6)
(式(6)中、Rは水素原子またはメチル基を表し、Xは炭素数1〜10のアルキル基である。)
Figure 2021154220
(7)
(式(7)中、Yは、水素原子またはアルカリ金属原子を表し、Zは、−CONHC(CHCHSONaを表し、h,l,m,nはそれぞれ0または正の整数であり、h+l+m+nは、1〜100の整数である。)
Figure 2021154220
(8)
(式(8)中、Yは、水素原子またはアルカリ金属原子を表し、m,nはそれぞれ0または正の整数であり、m+nは、1〜100の整数である。)
Figure 2021154220
(9)
(式(9)中、YおよびYは、それぞれ独立に水素原子またはアルカリ金属原子を表す。)
Figure 2021154220
(10)
(式(10)中、YおよびYは、それぞれ独立に水素原子またはアルカリ金属原子を表す。) In the water treatment agent composition, the scale inhibitor is a polymer containing a monomer unit of the formula (1), a polymer containing a monomer unit of the formula (2), and a monomer of the formula (1). A copolymer containing a unit and a monomer unit of the formula (3), a monomer unit of the formula (1), a monomer unit of the formula (3), and a monomer unit of the formula (4). A copolymer containing a monomer unit of the formula (2), a monomer unit of the formula (5), and a monomer unit of the formula (6), and a phosphinocarboxylic acid of the formula (7). Polymer, bis (poly-2-carboxyethyl) phosphinic acid of formula (8), 2-phosphonobutane-1,2,4-tricarboxylic acid of formula (9) and salts thereof, 1-hydroxyethylidene of formula (10). It is preferably at least one of -1,1-diphosphonic acid and a salt thereof.
Figure 2021154220
(1)
(In formula (1), R 1 represents a hydrogen atom or a methyl group, and X 1 represents a hydrogen atom, a monovalent or divalent metal atom, an ammonium group or an organic ammonium group.)
Figure 2021154220
(2)
(In formula (2), R 2 and R 3 independently represent a hydrogen atom or a methyl group, and X 2 and X 3 independently represent a hydrogen atom, a monovalent or divalent metal atom, an ammonium group or an organic ammonium. Represents a group.)
Figure 2021154220
(3)
(In the formula (3), R 4 represents a hydrogen atom or a methyl group, and X 4 is an alkyl sulfonic acid group having 1 to 10 carbon atoms or a salt thereof, or an aryl sulfonic acid group having 6 to 10 carbon atoms or a salt thereof. In the case of a salt, it is a monovalent or divalent metal salt, an ammonium salt or an organic ammonium salt.)
Figure 2021154220
(4)
(In formula (4), R 5 represents a hydrogen atom or a methyl group, and X 5 and X 6 independently represent a hydrogen atom or an alkyl group having 1 to 10 carbon atoms, but at least one of them has 1 to 10 carbon atoms. It is an alkyl group of.)
Figure 2021154220
(5)
(In formula (5), R 6 represents a hydrogen atom or a methyl group, and X 7 is an alkyl group having 1 to 10 carbon atoms.)
Figure 2021154220
(6)
(In formula (6), R 7 represents a hydrogen atom or a methyl group, and X 8 is an alkyl group having 1 to 10 carbon atoms.)
Figure 2021154220
(7)
(In formula (7), Y represents a hydrogen atom or an alkali metal atom, Z represents −CONHC (CH 3 ) 2 CH 2 SO 3 Na, and h, l, m, and n are 0 or positive, respectively. It is an integer, and h + l + m + n is an integer of 1 to 100.)
Figure 2021154220
(8)
(In formula (8), Y represents a hydrogen atom or an alkali metal atom, m and n are 0 or positive integers, respectively, and m + n is an integer of 1 to 100.)
Figure 2021154220
(9)
(In formula (9), Y 1 and Y 2 independently represent a hydrogen atom or an alkali metal atom, respectively.)
Figure 2021154220
(10)
(In formula (10), Y 3 and Y 4 independently represent a hydrogen atom or an alkali metal atom, respectively.)

前記水処理剤組成物において、前記水処理剤組成物のpHが12未満であることが好ましい。 In the water treatment agent composition, the pH of the water treatment agent composition is preferably less than 12.

前記水処理剤組成物において、前記ヨウ素系酸化剤および前記ヨウ化物の両方を含む場合、前記ヨウ素系酸化剤に対する、前記ヨウ化物の質量の比率が、1.2以上であることが好ましい。 When both the iodine-based oxidant and the iodide are contained in the water treatment agent composition, the ratio of the mass of the iodide to the iodine-based oxidant is preferably 1.2 or more.

本発明は、前記水処理剤組成物を用いて水を処理する水処理方法である。 The present invention is a water treatment method for treating water using the water treatment agent composition.

本発明によって、酸化剤系殺菌組成物のスライム抑制性能の著しい低下を抑制しつつ、スケール抑制剤を配合した一剤化された水処理剤組成物、およびその水処理剤組成物を用いた水処理方法を提供することができる。 According to the present invention, a single-agent water treatment agent composition containing a scale inhibitor and water using the water treatment agent composition while suppressing a significant decrease in slime suppression performance of the oxidant-based bactericidal composition. A processing method can be provided.

本発明の実施の形態について以下説明する。本実施形態は本発明を実施する一例であって、本発明は本実施形態に限定されるものではない。 Embodiments of the present invention will be described below. The present embodiment is an example of carrying out the present invention, and the present invention is not limited to the present embodiment.

本実施形態に係る水処理剤組成物は、ヨウ素系酸化剤と、ヨウ化物およびアルカリ剤のうちの少なくとも1つと、スケール抑制剤と、を含む組成物である。本実施形態に係る水処理剤組成物は、ヨウ素系酸化剤の溶解性、製剤のpHを大幅に上昇させない等の点から、ヨウ素系酸化剤と、ヨウ化物と、アルカリ剤と、スケール抑制剤と、を含むことが好ましい。本実施形態に係る水処理剤組成物は、さらに水を含んでもよい。 The water treatment agent composition according to the present embodiment is a composition containing an iodine-based oxidizing agent, at least one of an iodide and an alkaline agent, and a scale inhibitor. The water treatment agent composition according to the present embodiment has an iodine-based oxidizing agent, an iodide, an alkaline agent, and a scale inhibitor from the viewpoints of solubility of the iodine-based oxidizing agent and not significantly increasing the pH of the preparation. And, preferably. The water treatment agent composition according to the present embodiment may further contain water.

本発明者らは、ヨウ素系酸化剤と、ヨウ化物およびアルカリ剤のうちの少なくとも1つとを、スケール抑制剤と配合することによって、酸化剤系殺菌組成物のスライム抑制性能の著しい低下(すなわち、酸化力の著しい低下)を抑制しつつ、スケール抑制剤を配合した一剤化された水処理剤組成物が得られることを見出した。また、本実施形態に係る水処理剤組成物を用いると、被処理水に添加しても被処理水のpHを大幅に上昇させない。 By blending an iodine-based oxidizing agent and at least one of an iodide and an alkaline agent with a scale inhibitor, the present inventors significantly reduce the slime suppressing performance of the oxidizing agent-based bactericidal composition (that is,). It has been found that a single-agent water treatment agent composition containing a scale inhibitor can be obtained while suppressing (significant decrease in oxidizing power). Further, when the water treatment agent composition according to the present embodiment is used, the pH of the water to be treated is not significantly increased even if it is added to the water to be treated.

ヨウ素系酸化剤としては、ヨウ素(I)、ヨウ素酸塩、過ヨウ素酸塩等が挙げられる。これらのうち、ヨウ素が、殺菌性能、コスト等の観点から好ましい。 Examples of the iodine-based oxidizing agent include iodine (I 2 ), iodate, and periodate. Of these, iodine is preferable from the viewpoint of sterilization performance, cost and the like.

ヨウ化物としては、ヨウ化ナトリウム、ヨウ化カリウム、ヨウ化リチウム、ヨウ化アンモニウムおよびヨウ化水素酸等が挙げられる。これらのうち、溶解性等の点から、ヨウ化カリウムが好ましい。 Examples of the iodide include sodium iodide, potassium iodide, lithium iodide, ammonium iodide, hydroiodic acid and the like. Of these, potassium iodide is preferable from the viewpoint of solubility and the like.

アルカリ剤としては、水酸化ナトリウム、水酸化カリウム等の水酸化アルカリ、炭酸ナトリウム、炭酸カリウム等の炭酸アルカリ等が挙げられる。これらのうち、水酸化アルカリが好ましく、ヨウ素系酸化剤の溶解性等の点から、水酸化カリウムが好ましい。また、アルカリ剤は、固形でなく、水溶液として用いてもよい。 Examples of the alkaline agent include alkali hydroxides such as sodium hydroxide and potassium hydroxide, and alkali carbonates such as sodium carbonate and potassium carbonate. Of these, alkali hydroxide is preferable, and potassium hydroxide is preferable from the viewpoint of solubility of an iodine-based oxidizing agent and the like. Moreover, the alkaline agent may be used as an aqueous solution instead of a solid.

ヨウ化物およびアルカリ剤のうち、ヨウ素系酸化剤の溶解性等の点から、ヨウ化カリウム等のヨウ化物が好ましく、ヨウ化物およびアルカリ剤の両者を含むことがより好ましい。 Of the iodide and the alkaline agent, an iodide such as potassium iodide is preferable from the viewpoint of solubility of the iodine-based oxidizing agent, and it is more preferable to contain both the iodide and the alkaline agent.

スケール抑制剤としては、例えば、下記式(1)の単量体単位を含む重合体、下記式(2)の単量体単位を含む重合体、下記式(1)の単量体単位と下記式(3)の単量体単位とを含む共重合体、下記式(1)の単量体単位と下記式(3)の単量体単位と下記式(4)の単量体単位とを含む共重合体、下記式(2)の単量体単位と下記式(5)の単量体単位と下記式(6)の単量体単位とを含む共重合体、下記式(7)のホスフィノカルボン酸共重合体、下記式(8)のビス(ポリ−2−カルボキシエチル)ホスフィン酸、下記式(9)の2−ホスホノブタン−1,2,4−トリカルボン酸およびその塩、下記式(10)の1−ヒドロキシエチリデン−1,1−ジホスホン酸およびその塩、アミノトリメチレンホスホン酸、ジエチレントリアミンペンタメチレンホスホン酸等が挙げられる。 Examples of the scale inhibitor include a polymer containing a monomer unit of the following formula (1), a polymer containing a monomer unit of the following formula (2), a monomer unit of the following formula (1) and the following. A polymer containing the monomer unit of the formula (3), the monomer unit of the following formula (1), the monomer unit of the following formula (3), and the monomer unit of the following formula (4). A copolymer containing, a polymer containing a monomer unit of the following formula (2), a monomer unit of the following formula (5), and a monomer unit of the following formula (6), of the following formula (7) Phosphinocarboxylic acid copolymer, bis (poly-2-carboxyethyl) phosphinic acid of the following formula (8), 2-phosphonobutane-1,2,4-tricarboxylic acid of the following formula (9) and a salt thereof, the following formula Examples of (10) 1-hydroxyethylidene-1,1-diphosphonic acid and salts thereof, aminotrimethylenephosphonic acid, diethylenetriaminepentamethylenephosphonic acid and the like can be mentioned.

スケール抑制剤としては、下記式(1)の単量体単位からなる重合体、下記式(2)の単量体単位からなる重合体、下記式(1)の単量体単位と下記式(3)の単量体単位とからなる二元共重合体、下記式(1)の単量体単位と下記式(3)の単量体単位と下記式(4)の単量体単位とからなる三元共重合体、下記式(2)の単量体単位と下記式(5)の単量体単位と下記式(6)の単量体単位とを含む三元共重合体、下記式(7)のホスフィノカルボン酸共重合体、下記式(8)のビス(ポリ−2−カルボキシエチル)ホスフィン酸、下記式(9)の2−ホスホノブタン−1,2,4−トリカルボン酸およびその塩、下記式(10)の1−ヒドロキシエチリデン−1,1−ジホスホン酸およびその塩が好ましい。 Examples of the scale inhibitor include a polymer composed of the monomer unit of the following formula (1), a polymer composed of the monomer unit of the following formula (2), the monomer unit of the following formula (1) and the following formula ( From a binary copolymer composed of the monomer unit of 3), the monomer unit of the following formula (1), the monomer unit of the following formula (3), and the monomer unit of the following formula (4). A ternary copolymer comprising the monomer unit of the following formula (2), the monomer unit of the following formula (5), and the monomer unit of the following formula (6), the following formula The phosphinocarboxylic acid copolymer of (7), the bis (poly-2-carboxyethyl) phosphinic acid of the following formula (8), the 2-phosphonobutane-1,2,4-tricarboxylic acid of the following formula (9) and the like thereof. Salts, 1-hydroxyethylidene-1,1-diphosphonic acid of the following formula (10) and salts thereof are preferable.

これらのうち、下記式(1)の単量体単位を含む重合体、下記式(2)の単量体単位を含む重合体、下記式(1)の単量体単位と下記式(3)の単量体単位とを含む共重合体、下記式(1)の単量体単位と下記式(3)の単量体単位と下記式(4)の単量体単位とを含む共重合体、下記式(2)の単量体単位と下記式(5)の単量体単位と下記式(6)の単量体単位とを含む共重合体、下記式(7)のホスフィノカルボン酸共重合体、下記式(8)のビス(ポリ−2−カルボキシエチル)ホスフィン酸、下記式(9)の2−ホスホノブタン−1,2,4−トリカルボン酸およびその塩、下記式(10)の1−ヒドロキシエチリデン−1,1−ジホスホン酸およびその塩は、通常、スケール抑制剤としての機能の他に、鉄系金属用の金属防食剤としても機能する。 Among these, a polymer containing a monomer unit of the following formula (1), a polymer containing a monomer unit of the following formula (2), a monomer unit of the following formula (1) and the following formula (3) Polymer containing the above-mentioned monomer unit, the following formula (1), the following formula (3), and the following formula (4). , A copolymer containing a monomer unit of the following formula (2), a monomer unit of the following formula (5), and a monomer unit of the following formula (6), and a phosphinocarboxylic acid of the following formula (7). Copolymer, bis (poly-2-carboxyethyl) phosphinic acid of the following formula (8), 2-phosphonobutane-1,2,4-tricarboxylic acid of the following formula (9) and a salt thereof, of the following formula (10) 1-Hydroxyethylidene-1,1-diphosphonic acid and salts thereof usually function not only as a scale inhibitor but also as a metal anticorrosive agent for iron-based metals.

Figure 2021154220
(1)
(式(1)中、Rは水素原子またはメチル基を表し、Xは水素原子、1価もしくは2価の金属原子、アンモニウム基または有機アンモニウム基を表す。)
Figure 2021154220
(1)
(In formula (1), R 1 represents a hydrogen atom or a methyl group, and X 1 represents a hydrogen atom, a monovalent or divalent metal atom, an ammonium group or an organic ammonium group.)

Figure 2021154220
(2)
(式(2)中、RとRはそれぞれ独立に水素原子またはメチル基を表し、XとXはそれぞれ独立に水素原子、1価もしくは2価の金属原子、アンモニウム基または有機アンモニウム基を表す。)
Figure 2021154220
(2)
(In formula (2), R 2 and R 3 independently represent a hydrogen atom or a methyl group, and X 2 and X 3 independently represent a hydrogen atom, a monovalent or divalent metal atom, an ammonium group or an organic ammonium. Represents a group.)

Figure 2021154220
(3)
(式(3)中、Rは水素原子またはメチル基を表し、Xは炭素数1〜10のアルキルスルホン酸基もしくはその塩、または、炭素数6〜10のアリールスルホン酸基もしくはその塩を表し、塩の場合は1価もしくは2価の金属塩、アンモニウム塩または有機アンモニウム塩である。)
Figure 2021154220
(3)
(In the formula (3), R 4 represents a hydrogen atom or a methyl group, and X 4 is an alkyl sulfonic acid group having 1 to 10 carbon atoms or a salt thereof, or an aryl sulfonic acid group having 6 to 10 carbon atoms or a salt thereof. In the case of a salt, it is a monovalent or divalent metal salt, an ammonium salt or an organic ammonium salt.)

Figure 2021154220
(4)
(式(4)中、Rは水素原子またはメチル基を表し、XとXはそれぞれ独立に水素原子または炭素数1〜10のアルキル基を表すが、少なくとも一方が炭素数1〜10のアルキル基である。)
Figure 2021154220
(4)
(In formula (4), R 5 represents a hydrogen atom or a methyl group, and X 5 and X 6 independently represent a hydrogen atom or an alkyl group having 1 to 10 carbon atoms, but at least one of them has 1 to 10 carbon atoms. It is an alkyl group of.)

Figure 2021154220
(5)
(式(5)中、Rは水素原子またはメチル基を表し、Xは炭素数1〜10のアルキル基である。)
Figure 2021154220
(5)
(In formula (5), R 6 represents a hydrogen atom or a methyl group, and X 7 is an alkyl group having 1 to 10 carbon atoms.)

Figure 2021154220
(6)
(式(6)中、Rは水素原子またはメチル基を表し、Xは炭素数1〜10のアルキル基である。)
Figure 2021154220
(6)
(In formula (6), R 7 represents a hydrogen atom or a methyl group, and X 8 is an alkyl group having 1 to 10 carbon atoms.)

Figure 2021154220
(7)
(式(7)中、Yは、水素原子またはアルカリ金属原子を表し、Zは、−CONHC(CHCHSONaを表し、h,l,m,nはそれぞれ0または正の整数であり、h+l+m+nは、1〜100の整数である。)
Figure 2021154220
(7)
(In formula (7), Y represents a hydrogen atom or an alkali metal atom, Z represents −CONHC (CH 3 ) 2 CH 2 SO 3 Na, and h, l, m, and n are 0 or positive, respectively. It is an integer, and h + l + m + n is an integer of 1 to 100.)

Figure 2021154220
(8)
(式(8)中、Yは、水素原子またはアルカリ金属原子を表し、m,nはそれぞれ0または正の整数であり、m+nは、1〜100の整数である。)
Figure 2021154220
(8)
(In formula (8), Y represents a hydrogen atom or an alkali metal atom, m and n are 0 or positive integers, respectively, and m + n is an integer of 1 to 100.)

Figure 2021154220
(9)
(式(9)中、YおよびYは、それぞれ独立に水素原子またはアルカリ金属原子を表す。)
Figure 2021154220
(9)
(In formula (9), Y 1 and Y 2 independently represent a hydrogen atom or an alkali metal atom, respectively.)

Figure 2021154220
(10)
(式(10)中、YおよびYは、それぞれ独立に水素原子またはアルカリ金属原子を表す。)
Figure 2021154220
(10)
(In formula (10), Y 3 and Y 4 independently represent a hydrogen atom or an alkali metal atom, respectively.)

なお、式(1)〜(3)における有機アンモニウム塩としては、例えば、炭素原子数が1〜4のアルキル基またはヒドロキシアルキル基を有するアルキルアンモニウム基または(ヒドロキシ)アルキルアンモニウム基が好ましい。 As the organic ammonium salt in the formulas (1) to (3), for example, an alkylammonium group or a (hydroxy) alkylammonium group having an alkyl group having 1 to 4 carbon atoms or a hydroxyalkyl group is preferable.

式(1)〜(3)における1価もしくは2価の金属塩としては、ナトリウム塩、カリウム塩、カルシウム塩、マグネシウム塩等が挙げられる。 Examples of the monovalent or divalent metal salt in the formulas (1) to (3) include sodium salt, potassium salt, calcium salt, magnesium salt and the like.

式(3)におけるXがアルキルスルホン酸基もしくはその塩である場合のアルキル基としては、炭素原子数が1〜8のアルキル基が好ましい。Xがアリールスルホン酸基もしくはその塩である場合のアリール基としては、炭素原子数が6〜10のアリール基またはアリールアルキル基が好ましい。 When X 4 in the formula (3) is an alkyl sulfonic acid group or a salt thereof, the alkyl group preferably has an alkyl group having 1 to 8 carbon atoms. When X 4 is an aryl sulfonic acid group or a salt thereof, the aryl group is preferably an aryl group having 6 to 10 carbon atoms or an arylalkyl group.

式(4)〜(6)におけるアルキル基としては、炭素原子数が1〜8のアルキル基が好ましい。 As the alkyl group in the formulas (4) to (6), an alkyl group having 1 to 8 carbon atoms is preferable.

式(1)の単量体単位と式(3)の単量体単位とからなる二元共重合体における単量体単位の重量比率としては、1〜99:99〜1であることが好ましい。 The weight ratio of the monomer unit in the binary copolymer composed of the monomer unit of the formula (1) and the monomer unit of the formula (3) is preferably 1 to 99: 99 to 1. ..

式(1)の単量体単位と式(3)の単量体単位と式(4)の単量体単位とからなる三元共重合体における単量体単位の重量比率としては、1〜98:1〜98:1〜98であることが好ましい。 The weight ratio of the monomer unit in the ternary copolymer composed of the monomer unit of the formula (1), the monomer unit of the formula (3) and the monomer unit of the formula (4) is 1 to 1. It is preferably 98: 1 to 98: 1 to 98.

式(2)の単量体単位と式(5)の単量体単位と式(6)の単量体単位とからなる三元共重合体における単量体単位の重量比率としては、1〜98:1〜98:1〜98であることが好ましい。 The weight ratio of the monomer unit in the ternary copolymer composed of the monomer unit of the formula (2), the monomer unit of the formula (5) and the monomer unit of the formula (6) is 1 to 1. It is preferably 98: 1 to 98: 1 to 98.

式(1)〜(6)の単量体単位を含む重合体の重量平均分子量は、500〜100,000の範囲が好ましい。重量平均分子量が500未満あるいは100,000を超えると、スケール抑制性能が低下する場合がある。 The weight average molecular weight of the polymer containing the monomer units of the formulas (1) to (6) is preferably in the range of 500 to 100,000. If the weight average molecular weight is less than 500 or more than 100,000, the scale suppression performance may be deteriorated.

式(7)のホスフィノカルボン酸共重合体の重量平均分子量は、500〜100,000の範囲が好ましい。重量平均分子量が500未満あるいは100,000を超えると、スケール抑制性能が低下する場合がある。式(8)のビス(ポリ−2−カルボキシエチル)ホスフィン酸の重量平均分子量は、500〜100,000の範囲が好ましい。重量平均分子量が500未満あるいは100,000を超えると、スケール抑制性能が低下する場合がある。 The weight average molecular weight of the phosphinocarboxylic acid copolymer of the formula (7) is preferably in the range of 500 to 100,000. If the weight average molecular weight is less than 500 or more than 100,000, the scale suppression performance may be deteriorated. The weight average molecular weight of the bis (poly-2-carboxyethyl) phosphinic acid of the formula (8) is preferably in the range of 500 to 100,000. If the weight average molecular weight is less than 500 or more than 100,000, the scale suppression performance may be deteriorated.

式(7),(8),(9),(10)におけるアルカリ金属原子としては、ナトリウム原子、カリウム原子が好ましく、ナトリウム原子がより好ましい。式(9)のYおよびYが水素原子である2−ホスホノブタン−1,2,4−トリカルボン酸は、以下の化合物である。

Figure 2021154220
As the alkali metal atom in the formulas (7), (8), (9) and (10), a sodium atom and a potassium atom are preferable, and a sodium atom is more preferable. The 2-phosphonobutane-1,2,4-tricarboxylic acid in which Y 1 and Y 2 of the formula (9) are hydrogen atoms is the following compound.
Figure 2021154220

式(10)のYおよびYが水素原子である1−ヒドロキシエチリデン−1,1−ジホスホン酸は、以下の化合物である。

Figure 2021154220
1-Hydroxyethylidene-1,1-diphosphonic acid in which Y 3 and Y 4 of the formula (10) are hydrogen atoms is the following compound.
Figure 2021154220

本実施形態に係る水処理剤組成物に含まれる全ヨウ素濃度は、組成物全体の量に対して0.7重量%〜5.0重量%の範囲であることが好ましい。全ヨウ素濃度が組成物全体の量に対して0.7重量%未満であると、生物付着の制御に劣る場合があり、5.0重量%を超えると、保存性等の製剤安定性が損なわれる場合がある。 The total iodine concentration contained in the water treatment agent composition according to the present embodiment is preferably in the range of 0.7% by weight to 5.0% by weight with respect to the total amount of the composition. If the total iodine concentration is less than 0.7% by weight based on the total amount of the composition, the control of biofouling may be inferior, and if it exceeds 5.0% by weight, the pharmaceutical stability such as storage stability is impaired. May occur.

本実施形態に係る水処理剤組成物の製剤pHは、12未満であることが好ましく、3以上12未満の範囲であることがより好ましく、5以上10以下の範囲がさらに好ましい。製剤pHが12以上であると、被処理水のpHが上昇しスケール成分が析出しやすくなる。また、製剤pHが3未満であると、被処理水のpHが低下し鉄系や銅系金属が腐食しやすくなる。 The pharmaceutical pH of the water treatment agent composition according to the present embodiment is preferably less than 12, more preferably 3 or more and less than 12, and even more preferably 5 or more and 10 or less. When the pH of the preparation is 12 or more, the pH of the water to be treated rises and scale components are likely to precipitate. Further, when the pH of the preparation is less than 3, the pH of the water to be treated is lowered and iron-based and copper-based metals are easily corroded.

本実施形態に係る水処理剤組成物において、ヨウ素系酸化剤およびヨウ化物の両方を含む場合、ヨウ素系酸化剤に対する、ヨウ化物の質量の比率(ヨウ化物/ヨウ素系酸化剤)は、1.0以上であることが好ましく、1.2以上であることがより好ましく、1.7以上5.0以下であることがさらに好ましい。上記比率が1.0未満であると、不溶化物の量が増える場合があり、5.0を超えると、配合量に見合うほどの製剤安定化効果が得られず不経済になる場合がある。 When both the iodine-based oxidant and the iodide are contained in the water treatment agent composition according to the present embodiment, the ratio of the mass of the iodide to the iodine-based oxidant (iodine / iodine-based oxidant) is 1. It is preferably 0 or more, more preferably 1.2 or more, and further preferably 1.7 or more and 5.0 or less. If the above ratio is less than 1.0, the amount of the insoluble matter may increase, and if it exceeds 5.0, the formulation stabilizing effect commensurate with the blending amount may not be obtained, which may be uneconomical.

本実施形態に係る水処理剤組成物において、ヨウ素系酸化剤およびヨウ化物の両方を含む場合、ヨウ素系酸化剤とヨウ化物との和に対するアルカリ剤の質量の比率[アルカリ剤/(ヨウ素系酸化剤+ヨウ化物)]は、製剤中のヨウ素保存安定性を向上させるため、0.4未満であることが好ましく、0.3未満であることがより好ましい。上記比率が0.4を超えると、ヨウ素系酸化剤成分の無効消費量が増え、また、製剤の保存中にヨウ素濃度が低下してしまう場合がある。 When both the iodine-based oxidizing agent and the iodide are contained in the water treatment agent composition according to the present embodiment, the ratio of the mass of the alkaline agent to the sum of the iodine-based oxidizing agent and the iodide [alkali agent / (iodine-based oxidation). Agent + iodide)] is preferably less than 0.4, more preferably less than 0.3, in order to improve the iodine storage stability in the formulation. If the above ratio exceeds 0.4, the ineffective consumption of the iodine-based oxidant component increases, and the iodine concentration may decrease during the storage of the pharmaceutical product.

本実施形態に係る水処理剤組成物において、ヨウ化物およびアルカリ剤のうちアルカリ剤のみを含む場合、水処理剤組成物の製剤直後のpHが8.4以上10.0以下であることが好ましく、9.0以上9.7以下であることがより好ましい。上記pHが8.4未満であると、不溶化物の量が増える場合があり、10.0を超えると、製剤中のヨウ素濃度が低下する場合がある。 When the water treatment agent composition according to the present embodiment contains only the alkaline agent among the iodide and the alkaline agent, the pH immediately after the preparation of the water treatment agent composition is preferably 8.4 or more and 10.0 or less. , 9.0 or more and 9.7 or less is more preferable. If the pH is less than 8.4, the amount of insoluble matter may increase, and if it exceeds 10.0, the iodine concentration in the preparation may decrease.

<水処理剤組成物の製造方法>
本実施形態に係る水処理剤組成物は、例えば、ヨウ素系酸化剤と、ヨウ化物およびアルカリ剤のうちの少なくとも1つと、スケール抑制剤とを混合することにより得られ、例えば、ヨウ素系酸化剤と、ヨウ化物およびアルカリ剤のうちの少なくとも1つと、スケール抑制剤と、水とを混合することにより得られる。
<Manufacturing method of water treatment agent composition>
The water treatment agent composition according to the present embodiment is obtained by mixing, for example, an iodine-based oxidizing agent, at least one of an iodide and an alkaline agent, and a scale inhibitor, for example, an iodine-based oxidizing agent. And at least one of iodide and alkaline agents, scale inhibitors and water.

<水処理剤組成物を用いた水処理方法>
本実施形態に係る水処理剤組成物は、冷却水系、冷温水系、純水製造工程水系、排水回収工程水系、紙パルプ工程水系、集塵水系等の様々な水系において、用いることができる。本実施形態に係る水処理剤組成物は、例えば、冷却水等の工業用水システムの水処理や、生物付着汚染の進んだ配管洗浄等の水処理方法等に用いることができる。
<Water treatment method using a water treatment agent composition>
The water treatment agent composition according to the present embodiment can be used in various water systems such as a cooling water system, a cold / hot water system, a pure water production process water system, a wastewater recovery process water system, a paper pulp process water system, and a dust collecting water system. The water treatment agent composition according to the present embodiment can be used, for example, for water treatment of industrial water systems such as cooling water, water treatment methods such as pipe cleaning with advanced biofouling and contamination.

本実施形態に係る水処理剤組成物を添加した水系における全ヨウ素濃度は、0.1〜150mg/Lであることが好ましい。水処理剤組成物を添加した水系における全ヨウ素濃度が0.1mg/L未満であると、十分なスライム抑制効果を得ることができない場合があり、150mg/Lより多いと、系内の金属材質を腐食させる場合がある。 The total iodine concentration in the water system to which the water treatment agent composition according to the present embodiment is added is preferably 0.1 to 150 mg / L. If the total iodine concentration in the water system to which the water treatment agent composition is added is less than 0.1 mg / L, a sufficient slime suppressing effect may not be obtained, and if it is more than 150 mg / L, the metal material in the system. May corrode.

以下、実施例および比較例を挙げ、本発明をより具体的に詳細に説明するが、本発明は、以下の実施例に限定されるものではない。 Hereinafter, the present invention will be described in more detail with reference to Examples and Comparative Examples, but the present invention is not limited to the following Examples.

<実施例1〜18>
実施例については、表1〜表4に示す配合組成(重量%)および順番で添加(表の上から順番に添加)して製剤化を行った。製剤化は、PTFE(ポリテトラフルオロエチレン)製の容器内で、室温(25℃)以下に冷却し、スターラで撹拌しながら各薬剤を添加して行った。
<Examples 1 to 18>
Examples were formulated by adding the compounding compositions (% by weight) shown in Tables 1 to 4 in order (added in order from the top of the table). The formulation was carried out in a container made of PTFE (polytetrafluoroethylene), cooled to room temperature (25 ° C.) or lower, and each drug was added while stirring with a stirrer.

Figure 2021154220
Figure 2021154220

Figure 2021154220
Figure 2021154220

Figure 2021154220
Figure 2021154220

Figure 2021154220
Figure 2021154220

表1〜表4において、「PAA」は、アクリル酸単独重合体(重量平均分子量約4,500)、「AABI」は、アクリル酸と、2−アクリルアミド−2−メチルプロパンスルホン酸のアクリル酸系二元共重合体(重量平均分子量約4,500)、「AATER」は、アクリル酸と、2−アクリルアミド−2−メチルプロパンスルホン酸と、アルキルアクリルアミドのアクリル酸系三元共重合体(重量平均分子量約4,500)、「PMAA」は、マレイン酸単独重合体(重量平均分子量約1,000)、「PMAVA」は、マレイン酸と、アクリル酸エチルと、ビニルアセテートのマレイン酸系三元重合体(重量平均分子量約1,000)である。「PCABI」は、式(7)のホスフィノカルボン酸共重合体(h+l+m+nの平均値が約16)、「BCAP」は、式(8)のビス(ポリ−2−カルボキシエチル)ホスフィン酸(m+nの平均値が約16)、「PBTC」は、2−ホスホノブタン−1,2,4−トリカルボン酸、「HEDP」は、1−ヒドロキシエチリデン−1,1−ジホスホン酸である。水酸化カリウムは、関東化学社製の特級試薬、ヨウ化カリウムとヨウ素は、富士フィルム和光純薬社製の特級試薬を用いた。 In Tables 1 to 4, "PAA" is an acrylic acid homopolymer (weight average molecular weight of about 4,500), and "AABI" is an acrylic acid system of acrylic acid and 2-acrylamide-2-methylpropanesulfonic acid. Binary copolymer (weight average molecular weight about 4,500), "AATER" is an acrylic acid-based ternary copolymer of acrylic acid, 2-acrylamide-2-methylpropansulfonic acid, and alkylacrylamide (weight average). Molecular weight of about 4,500), "PMAA" is a maleic acid homopolymer (weight average molecular weight of about 1,000), and "PMAVA" is a maleic acid-based ternary weight of maleic acid, ethyl acrylate, and vinyl acetate. It is a coalescence (weight average molecular weight of about 1,000). "PCABI" is a phosphinocarboxylic acid copolymer of formula (7) (the average value of h + l + m + n is about 16), and "BCAP" is bis (poly-2-carboxyethyl) phosphinic acid (m + n) of formula (8). "PBTC" is 2-phosphonobutane-1,2,4-tricarboxylic acid, and "HEDP" is 1-hydroxyethylidene-1,1-diphosphonic acid. For potassium hydroxide, a special grade reagent manufactured by Kanto Chemical Co., Inc. was used, and for potassium iodide and iodine, a special grade reagent manufactured by Fuji Film Wako Pure Chemical Industries, Ltd. was used.

なお、pHの測定は、以下の条件で行った。
電極タイプ:ガラス電極式
pH測定計:東亜ディーケーケー社製、IOL−30型
電極の校正:関東化学社製フタル酸塩pH(4.01)、標準液(第2種)、同社製中性リン酸塩pH(6.86)標準液(第2種)の2点校正で行った
測定温度:25℃
測定値:測定液に電極を浸漬し、安定後の値を測定値とし、3回測定の平均値
The pH was measured under the following conditions.
Electrode type: Glass electrode type pH meter: Toa DKK, IOL-30 type Electrode calibration: Kanto Chemical Co., Ltd. Phosphate pH (4.01), standard solution (type 2), neutral phosphorus manufactured by the same company Measurement temperature performed by two-point calibration of phosphate pH (6.86) standard solution (type 2): 25 ° C.
Measured value: The electrode is immersed in the measuring solution, and the value after stabilization is used as the measured value, which is the average value of three measurements.

実施例において、遊離ハロゲン濃度および全ハロゲン濃度は、試料を1万倍希釈し、HACH社の多項目水質分析計DR/3900を用いて、有効塩素測定法(DPD(ジエチル−p−フェニレンジアミン)法)により測定した。なお、遊離ヨウ素濃度および全ヨウ素濃度は、遊離塩素濃度、全塩素濃度として値を求めた後、塩素とヨウ素の分子量から算出した値を用いた。また、各水処理剤組成物について、25℃、遮光下で10日間保存したあとの全ヨウ素濃度を測定し、製剤化直後の全ヨウ素濃度に対する残存率を算出した。また、表1,2,3,4の組成物については、不溶化物の有無を目視で確認した。 In the examples, the free halogen concentration and the total halogen concentration were obtained by diluting the sample 10,000 times and using a multi-item water quality analyzer DR / 3900 manufactured by HACH to measure effective chlorine (DPD (diethyl-p-phenylenediamine)). Measured by method). For the free iodine concentration and the total iodine concentration, the values calculated from the molecular weights of chlorine and iodine were used after obtaining the values as the free chlorine concentration and the total chlorine concentration. In addition, the total iodine concentration of each water treatment agent composition after being stored at 25 ° C. in the dark for 10 days was measured, and the residual ratio with respect to the total iodine concentration immediately after the formulation was calculated. Further, with respect to the compositions shown in Tables 1, 2, 3 and 4, the presence or absence of insoluble matter was visually confirmed.

実施例の組成物では、酸化剤系スライム抑制剤であるヨウ素系酸化剤と、特定のポリマとをpH10未満で配合することにより、無機系スライム抑制剤のスライム抑制性能の著しい低下(酸化力の著しい低下)を抑制しつつ、一剤化することができた。また、表1,2のヨウ素系酸化剤およびヨウ化物の両方を含む組成物については、ヨウ素系酸化剤に対するヨウ化物の質量比が1.2以上である場合に、不溶化物を生成させずにヨウ素系酸化剤とポリマとを一剤化することができ、製剤化直後の全ヨウ素濃度は2.8重量%以上と、高濃度のヨウ素を含有する組成物が得られた。表3,4のヨウ化物およびアルカリ剤のうちアルカリ剤のみを含む組成物については、製剤化直後のpHが9.0以上9.7以下の場合に、製剤化直後の全ヨウ素濃度は0.6重量%以上と、高濃度のヨウ素を含有する組成物が得られた。なお、いずれの実施例についても、全ヨウ素における遊離ヨウ素の割合は90%以上と、酸化力が高い状態のまま一剤化できていることもわかった。 In the composition of the example, by blending an iodine-based oxidizing agent, which is an oxidizing agent-based slime inhibitor, and a specific polymer at a pH of less than 10, the slime suppressing performance of the inorganic slime inhibitor is significantly reduced (oxidizing power). It was possible to make it a single agent while suppressing a significant decrease). Further, for the compositions containing both the iodine-based oxidant and the iodide in Tables 1 and 2, when the mass ratio of the iodide to the iodine-based oxidant is 1.2 or more, insoluble matter is not generated. The iodine-based oxidizing agent and the polymer could be unified, and the total iodine concentration immediately after formulation was 2.8% by weight or more, and a composition containing a high concentration of iodine was obtained. For the compositions containing only the alkaline agent among the iodides and alkaline agents in Tables 3 and 4, when the pH immediately after the formulation is 9.0 or more and 9.7 or less, the total iodine concentration immediately after the formulation is 0. A composition containing a high concentration of iodine, which is 6% by weight or more, was obtained. In each of the examples, the ratio of free iodine to total iodine was 90% or more, and it was also found that the product could be unified with high oxidizing power.

このように、酸化剤系殺菌組成物のスライム抑制性能の著しい低下を抑制しつつ、スケール抑制剤を配合した一剤化された水処理剤組成物が得られ、その水処理剤組成物を用いた水処理方法を提供することができた。
In this way, a single-agent water treatment agent composition containing a scale inhibitor can be obtained while suppressing a significant decrease in slime suppression performance of the oxidant-based bactericidal composition, and the water treatment agent composition is used. We were able to provide the existing water treatment method.

Claims (5)

ヨウ素系酸化剤と、
ヨウ化物およびアルカリ剤のうちの少なくとも1つと、
スケール抑制剤と、
を含むことを特徴とする水処理剤組成物。
Iodine-based oxidizer and
With at least one of the iodide and alkaline agent,
Scale inhibitor and
A water treatment agent composition comprising.
請求項1に記載の水処理剤組成物であって、
前記スケール抑制剤は、式(1)の単量体単位を含む重合体、式(2)の単量体単位を含む重合体、式(1)の単量体単位と式(3)の単量体単位とを含む共重合体、式(1)の単量体単位と式(3)の単量体単位と式(4)の単量体単位とを含む共重合体、式(2)の単量体単位と式(5)の単量体単位と式(6)の単量体単位とを含む共重合体、式(7)のホスフィノカルボン酸共重合体、式(8)のビス(ポリ−2−カルボキシエチル)ホスフィン酸、式(9)の2−ホスホノブタン−1,2,4−トリカルボン酸およびその塩、式(10)の1−ヒドロキシエチリデン−1,1−ジホスホン酸およびその塩のうちの少なくとも1つであることを特徴とする水処理剤組成物。
Figure 2021154220
(1)
(式(1)中、Rは水素原子またはメチル基を表し、Xは水素原子、1価もしくは2価の金属原子、アンモニウム基または有機アンモニウム基を表す。)
Figure 2021154220
(2)
(式(2)中、RとRはそれぞれ独立に水素原子またはメチル基を表し、XとXはそれぞれ独立に水素原子、1価もしくは2価の金属原子、アンモニウム基または有機アンモニウム基を表す。)
Figure 2021154220
(3)
(式(3)中、Rは水素原子またはメチル基を表し、Xは炭素数1〜10のアルキルスルホン酸基もしくはその塩、または、炭素数6〜10のアリールスルホン酸基もしくはその塩を表し、塩の場合は1価もしくは2価の金属塩、アンモニウム塩または有機アンモニウム塩である。)
Figure 2021154220
(4)
(式(4)中、Rは水素原子またはメチル基を表し、XとXはそれぞれ独立に水素原子または炭素数1〜10のアルキル基を表すが、少なくとも一方が炭素数1〜10のアルキル基である。)
Figure 2021154220
(5)
(式(5)中、Rは水素原子またはメチル基を表し、Xは炭素数1〜10のアルキル基である。)
Figure 2021154220
(6)
(式(6)中、Rは水素原子またはメチル基を表し、Xは炭素数1〜10のアルキル基である。)
Figure 2021154220
(7)
(式(7)中、Yは、水素原子またはアルカリ金属原子を表し、Zは、−CONHC(CHCHSONaを表し、h,l,m,nはそれぞれ0または正の整数であり、h+l+m+nは、1〜100の整数である。)
Figure 2021154220
(8)
(式(8)中、Yは、水素原子またはアルカリ金属原子を表し、m,nはそれぞれ0または正の整数であり、m+nは、1〜100の整数である。)
Figure 2021154220
(9)
(式(9)中、YおよびYは、それぞれ独立に水素原子またはアルカリ金属原子を表す。)
Figure 2021154220
(10)
(式(10)中、YおよびYは、それぞれ独立に水素原子またはアルカリ金属原子を表す。)
The water treatment agent composition according to claim 1.
The scale inhibitor is a polymer containing a monomer unit of the formula (1), a polymer containing a monomer unit of the formula (2), a monomer unit of the formula (1) and a simple unit of the formula (3). A polymer containing a metric unit, a polymer containing a monomer unit of the formula (1), a monomer unit of the formula (3), and a monomer unit of the formula (4), the formula (2). A copolymer containing the monomer unit of the formula (5), the monomer unit of the formula (6), and the phosphinocarboxylic acid copolymer of the formula (7), of the formula (8). Bis (poly-2-carboxyethyl) phosphinic acid, 2-phosphonobutane-1,2,4-tricarboxylic acid of formula (9) and salts thereof, 1-hydroxyethylidene-1,1-diphosphonic acid of formula (10) and A water treatment agent composition characterized by being at least one of the salts.
Figure 2021154220
(1)
(In formula (1), R 1 represents a hydrogen atom or a methyl group, and X 1 represents a hydrogen atom, a monovalent or divalent metal atom, an ammonium group or an organic ammonium group.)
Figure 2021154220
(2)
(In formula (2), R 2 and R 3 independently represent a hydrogen atom or a methyl group, and X 2 and X 3 independently represent a hydrogen atom, a monovalent or divalent metal atom, an ammonium group or an organic ammonium. Represents a group.)
Figure 2021154220
(3)
(In the formula (3), R 4 represents a hydrogen atom or a methyl group, and X 4 is an alkyl sulfonic acid group having 1 to 10 carbon atoms or a salt thereof, or an aryl sulfonic acid group having 6 to 10 carbon atoms or a salt thereof. In the case of a salt, it is a monovalent or divalent metal salt, an ammonium salt or an organic ammonium salt.)
Figure 2021154220
(4)
(In formula (4), R 5 represents a hydrogen atom or a methyl group, and X 5 and X 6 independently represent a hydrogen atom or an alkyl group having 1 to 10 carbon atoms, but at least one of them has 1 to 10 carbon atoms. It is an alkyl group of.)
Figure 2021154220
(5)
(In formula (5), R 6 represents a hydrogen atom or a methyl group, and X 7 is an alkyl group having 1 to 10 carbon atoms.)
Figure 2021154220
(6)
(In formula (6), R 7 represents a hydrogen atom or a methyl group, and X 8 is an alkyl group having 1 to 10 carbon atoms.)
Figure 2021154220
(7)
(In formula (7), Y represents a hydrogen atom or an alkali metal atom, Z represents −CONHC (CH 3 ) 2 CH 2 SO 3 Na, and h, l, m, and n are 0 or positive, respectively. It is an integer, and h + l + m + n is an integer of 1 to 100.)
Figure 2021154220
(8)
(In formula (8), Y represents a hydrogen atom or an alkali metal atom, m and n are 0 or positive integers, respectively, and m + n is an integer of 1 to 100.)
Figure 2021154220
(9)
(In formula (9), Y 1 and Y 2 independently represent a hydrogen atom or an alkali metal atom, respectively.)
Figure 2021154220
(10)
(In formula (10), Y 3 and Y 4 independently represent a hydrogen atom or an alkali metal atom, respectively.)
請求項1または2に記載の水処理剤組成物であって、
前記水処理剤組成物のpHが12未満であることを特徴とする水処理剤組成物。
The water treatment agent composition according to claim 1 or 2.
A water treatment agent composition characterized in that the pH of the water treatment agent composition is less than 12.
請求項1〜3のいずれか1項に記載の水処理剤組成物であって、
前記水処理剤組成物が前記ヨウ素系酸化剤および前記ヨウ化物の両方を含む場合、前記ヨウ素系酸化剤に対する、前記ヨウ化物の質量の比率が、1.2以上であることを特徴とする水処理剤組成物。
The water treatment agent composition according to any one of claims 1 to 3.
When the water treatment agent composition contains both the iodine-based oxidant and the iodide, the ratio of the mass of the iodide to the iodine-based oxidant is 1.2 or more. Treatment agent composition.
請求項1〜4のいずれか1項に記載の水処理剤組成物を用いて水を処理することを特徴とする水処理方法。 A water treatment method comprising treating water using the water treatment agent composition according to any one of claims 1 to 4.
JP2020057325A 2020-03-27 2020-03-27 Water treatment composition and water treatment method Active JP7465699B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2020057325A JP7465699B2 (en) 2020-03-27 2020-03-27 Water treatment composition and water treatment method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2020057325A JP7465699B2 (en) 2020-03-27 2020-03-27 Water treatment composition and water treatment method

Publications (2)

Publication Number Publication Date
JP2021154220A true JP2021154220A (en) 2021-10-07
JP7465699B2 JP7465699B2 (en) 2024-04-11

Family

ID=77919177

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020057325A Active JP7465699B2 (en) 2020-03-27 2020-03-27 Water treatment composition and water treatment method

Country Status (1)

Country Link
JP (1) JP7465699B2 (en)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4386005A (en) * 1981-01-06 1983-05-31 Chemical Sciences, Inc. Scale inhibitor for reverse osmosis water purification system
JPS61257206A (en) * 1985-05-04 1986-11-14 ザ ビ−.エフ.グツドリツチ カンパニ− Method of preventing growth of organism in reverse osmosis water purification system
JP2001129554A (en) * 1999-11-02 2001-05-15 Japan Organo Co Ltd Method and apparatus for making deionized water
JP2002193711A (en) * 2000-12-22 2002-07-10 Mitsubishi Gas Chem Co Inc Multi-function type water-treating agent
JP2013128927A (en) * 2013-02-14 2013-07-04 Miura Co Ltd Chemicals feeding control method of circulating water system and chemicals feeding control device of circulating water system
JP2013213234A (en) * 2012-03-30 2013-10-17 Kurita Water Ind Ltd Method for preventing scaling in steam generation equipment
JP2014079719A (en) * 2012-10-18 2014-05-08 Japan Organo Co Ltd Scale cleaning liquid composition and scale cleaning method
JP2018030132A (en) * 2017-11-16 2018-03-01 三浦工業株式会社 Method for treating service water

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4386005A (en) * 1981-01-06 1983-05-31 Chemical Sciences, Inc. Scale inhibitor for reverse osmosis water purification system
JPS61257206A (en) * 1985-05-04 1986-11-14 ザ ビ−.エフ.グツドリツチ カンパニ− Method of preventing growth of organism in reverse osmosis water purification system
JP2001129554A (en) * 1999-11-02 2001-05-15 Japan Organo Co Ltd Method and apparatus for making deionized water
JP2002193711A (en) * 2000-12-22 2002-07-10 Mitsubishi Gas Chem Co Inc Multi-function type water-treating agent
JP2013213234A (en) * 2012-03-30 2013-10-17 Kurita Water Ind Ltd Method for preventing scaling in steam generation equipment
JP2014079719A (en) * 2012-10-18 2014-05-08 Japan Organo Co Ltd Scale cleaning liquid composition and scale cleaning method
JP2013128927A (en) * 2013-02-14 2013-07-04 Miura Co Ltd Chemicals feeding control method of circulating water system and chemicals feeding control device of circulating water system
JP2018030132A (en) * 2017-11-16 2018-03-01 三浦工業株式会社 Method for treating service water

Also Published As

Publication number Publication date
JP7465699B2 (en) 2024-04-11

Similar Documents

Publication Publication Date Title
TWI527933B (en) Composition and method for controlling copper discharge and erosion of copper alloys in industrial systems
US20090186858A1 (en) Synergistic compositions
JP5665524B2 (en) Water treatment method for suppressing microbial damage in water
JP2009154113A (en) Sterilization treatment method for water system water
JP6200243B2 (en) Method for producing water treatment composition and water treatment method
JP6169654B2 (en) One-component water treatment composition with improved storage stability
WO2001007682A1 (en) Corrosion inhibition method suitable for use in potable water
KR102506078B1 (en) Compositions and methods for inhibiting corrosion and scale
AU2002214357A1 (en) Multifunctional water-treating composition and method of water-treating using the same
WO2002036503A1 (en) Multifunctional water-treating composition and method of water-treating using the same
JP2017214406A (en) Water treatment agent composition, method for producing water treatment agent composition and water treatment method
JP7465699B2 (en) Water treatment composition and water treatment method
JP2001259652A (en) Stable water treating agent composition containing hypochorite
JP6093620B2 (en) Oxidative slime control agent composition with high storage stability
JP6666433B2 (en) Water treatment agent composition and water treatment method
JP5559629B2 (en) Water-based metal anticorrosion method
JP4598330B2 (en) Anticorrosion method
JP4383614B2 (en) Stable water treatment composition containing hypochlorite
JP2010090107A (en) Microbicidal and algicidal composition, microbicidal and algicidal method in water system, and method for producing microbicidal and algicidal composition
JP6548870B2 (en) Method for controlling slime in papermaking process water
CN107249332B (en) Water treatment agent composition, method for producing water treatment agent composition, and water treatment method
JP2019108310A (en) Sterilization algicidal agent composition and sterilization algicidal method, water treatment agent composition and water treatment method
JP6934295B2 (en) Water treatment agent composition, water treatment method, and storage or use method of water treatment agent composition
JP6835106B2 (en) Water treatment agent
KR101003064B1 (en) Multifunctional cooling water treating composition not including divalent metal salt, and water-treating method using the same

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230104

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20231129

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20231219

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240125

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20240319

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20240401

R150 Certificate of patent or registration of utility model

Ref document number: 7465699

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150